What to expect in the Veradermics, Inc interview process

Based on publicly available sources, Veradermics, Inc. is a dermatologist-founded, late clinical-stage biopharmaceutical company headquartered in New Haven, Connecticut (located at 470 James Street). Launched around 2018–2019 by practicing dermatologists and hair-loss researchers Reid Waldman and Brett King, the company operates as a small-scale, highly focused organization.

Headcount data indicates a small, rapidly scaling team, with employee estimates ranging between 11 and 50 people, reflecting significant year-over-year growth (+135.0% / +27 people). The organization maintains a lean corporate structure that includes executive leadership, vice presidents, directors, managers, and specialized roles—such as a Vice President of Commercial Excellence and Strategic Analytics, a Director of Financial Planning, and a Manager of Clinical Trial Recruitment and Site Engagement.

Financially, Veradermics is backed by substantial capital, reporting $901.4M in total funding across 8 prior funding rounds, alongside recent public offerings aimed at accelerating sales efforts, broadening distribution channels, and advancing its lead investigational product, VDPHL01. The company's operations center heavily on clinical research, trial recruitment, and strategic commercialization within the dermatology and hair loss therapeutic market.